Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Simonaggio

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Bulletin Du Cancer|January 1, 2019
Audrey Simonaggio, Aurélien Marabelle
Bulletin Du Cancer|January 1, 2019
Yann-Alexandre Vano, Audrey Simonaggio, Constance Thibault, et al.
World Journal of Urology|January 2, 2021
Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinomaIvan Pourmir, Johanna Noel, Audrey Simonaggio, et al.
Cancers|February 11, 2021
Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest DevelopmentsAdrien Procureur, Audrey Simonaggio, Jean-Emmanuel Bibault, et al.
Cancers|January 13, 2021
Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)Audrey Simonaggio, Nicolas Epaillard, Cédric Pobel, et al.
International Journal of Molecular Sciences|July 27, 2022
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular InsightsAudrey Simonaggio, Damien Ambrosetti, Virginie Verkarre, et al.
Clinical Breast Cancer|February 24, 2020
Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor PalbociclibZoé Guillaume, Jacques Medioni, Agnes Lillo-Lelouet, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Resistance to cancer immunotherapy in metastatic renal cell carcinomaMarco Moreira, Cedric Pobel, Nicolas Epaillard, et al.
Bulletin Du Cancer|July 5, 2020
[Impact of molecular signatures on the choice of systemic treatment for metastatic kidney cancer]Audrey Simonaggio, Nicolas Epaillard, Reza Elaidi, et al.
Bulletin Du Cancer|June 27, 2022
Future treatment options in metastatic clear cell renal cell carcinomaAudrey Simonaggio, Marie Auvray-Kuentz, Adrien Rochand, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|January 1, 2019
Audrey Simonaggio, Aurélien Marabelle
Bulletin Du Cancer|January 1, 2019
Yann-Alexandre Vano, Audrey Simonaggio, Constance Thibault, et al.
World Journal of Urology|January 2, 2021
Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinomaIvan Pourmir, Johanna Noel, Audrey Simonaggio, et al.
Cancers|February 11, 2021
Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest DevelopmentsAdrien Procureur, Audrey Simonaggio, Jean-Emmanuel Bibault, et al.
Cancers|January 13, 2021
Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)Audrey Simonaggio, Nicolas Epaillard, Cédric Pobel, et al.
International Journal of Molecular Sciences|July 27, 2022
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular InsightsAudrey Simonaggio, Damien Ambrosetti, Virginie Verkarre, et al.
Clinical Breast Cancer|February 24, 2020
Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor PalbociclibZoé Guillaume, Jacques Medioni, Agnes Lillo-Lelouet, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Resistance to cancer immunotherapy in metastatic renal cell carcinomaMarco Moreira, Cedric Pobel, Nicolas Epaillard, et al.
Bulletin Du Cancer|July 5, 2020
[Impact of molecular signatures on the choice of systemic treatment for metastatic kidney cancer]Audrey Simonaggio, Nicolas Epaillard, Reza Elaidi, et al.
Bulletin Du Cancer|June 27, 2022
Future treatment options in metastatic clear cell renal cell carcinomaAudrey Simonaggio, Marie Auvray-Kuentz, Adrien Rochand, et al.
Pageof 2